GLOW Stack — GHK-Cu + TB-500 + BPC-157 (Separate Vials)
Longevity & tissue rejuvenation stack protocol
Quick Reference
Overview
The GLOW Stack delivers the same three-peptide combination as the pre-blended GLOW formulation — GHK-Cu (50 mg), TB-500 (10 mg), and BPC-157 (10 mg) — in separate vials, enabling independent dose titration of each compound. GHK-Cu is the anchor, activating over 4,000 genes involved in collagen synthesis, antioxidant defence, skin repair, and hair follicle regeneration via copper peptide signalling. TB-500 provides systemic tissue repair and anti-inflammatory support through thymosin beta-4's actin-modulating mechanism, promoting cellular migration and angiogenesis. BPC-157 contributes localized healing, gut barrier support, and nitric oxide pathway activation for enhanced vascular delivery. Reconstituting each vial separately allows the researcher to adjust GHK-Cu dosing independently of the repair peptides.
Dosing & Reconstitution Guide
| Phase | Daily Dose | Units | Volume |
|---|---|---|---|
| Daily (GHK-Cu) | 1 mg | 6 units | 0.06 mL |
| Daily (GHK-Cu) | 2 mg (advanced) | 12 units | 0.12 mL |
| Twice weekly (TB-500) | 2–2.5 mg per injection | 60–75 units | 0.60–0.75 mL |
| Daily (BPC-157) | 300–600 mcg | 9–18 units | 0.09–0.18 mL |
Reconstitution Instructions
Allow all three vials to reach room temperature before handling.
Reconstitute GHK-Cu: draw 3.0 mL bacteriostatic water with a sterile syringe; inject slowly down the vial wall and swirl until dissolved. A faint blue tint is expected — this is normal.
Reconstitute TB-500: draw 3.0 mL bacteriostatic water with a fresh syringe; inject slowly and swirl gently.
Reconstitute BPC-157: draw 3.0 mL bacteriostatic water with a fresh syringe; inject slowly and swirl gently.
Label each vial with the compound name and reconstitution date; refrigerate at 2–8 °C, protected from light. Use within 28 days.
This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.
Supplies Needed
- ✓GHK-Cu Vials (50 mg): 1 vial
- ✓TB-500 Vials (10 mg): 1–2 vials
- ✓BPC-157 Vials (10 mg): 1 vial
- ✓Insulin Syringes (U-100): 72 syringes
- ✓Bacteriostatic Water (10 mL): 1 bottle
- ✓Alcohol Swabs: 144 swabs
Dosing Protocol
GHK-Cu Schedule
Inject 1–2 mg subcutaneously once daily. Rotate sites between abdomen, thighs, and upper arms. For skin-focused research, injecting near the target area is recommended.
TB-500 Schedule
Inject 2.0–2.5 mg subcutaneously twice weekly (e.g., Monday and Thursday). TB-500 distributes systemically regardless of injection site.
BPC-157 Schedule
Inject 300–600 mcg subcutaneously once daily. For localized skin or wound targets, inject near the area of interest.
Cycle Structure
Run all three compounds concurrently for 4–8 weeks, followed by a 2–4 week rest. GHK-Cu may be extended for sustained skin research endpoints.
Storage & Handling
- ✓Lyophilized: Store all vials at −20 °C (−4 °F) in dry, dark conditions; minimize moisture exposure.
- ✓Reconstituted: Refrigerate each vial at 2–8 °C; keep clearly labelled and separate from one another.
- ✓A faint blue tint in reconstituted GHK-Cu is normal — this is the copper-peptide complex forming.
- ✓Do not freeze reconstituted solutions; ice crystal formation damages peptide structure.
- ✓Allow vials to reach room temperature before each use to minimize condensation.
- ✓Discard any vial that becomes cloudy or develops visible particles.
Important Notes
- ✓All products sold by JA Performance Peptides are intended strictly for laboratory research purposes and are not approved for human consumption, veterinary use, or therapeutic application. Not for human use.
- ✓Keep all three compounds in separate, clearly labelled vials — do not mix in the same syringe.
- ✓Use a fresh sterile syringe for each injection and each vial puncture.
- ✓TB-500 injection site does not significantly affect its systemic distribution.
- ✓For skin-focused research, GHK-Cu subcutaneous dosing may be combined with topical application to the target area.
- ✓Document daily doses, injection sites, and timing for each compound separately.